XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Director
Common stock
Common stock
Director
Additional Paid-in Capital
Additional Paid-in Capital
Director
Retained Earnings
Treasury Stock
Beginning balance, shares outstanding at Dec. 31, 2020     17,995,000          
Beginning Balance at Dec. 31, 2020 $ 240,502,000   $ 260,000   $ 239,989,000   $ 102,303,000 $ (102,050,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) 6,766,000           6,766,000  
Isuuance of common stock, shares     32,000 10,000        
Issuance of common stock $ 840,000 $ 337,000 $ 1,000   839,000 $ 337,000    
Exercise of stock options, shares 281,629   115,000          
Exercise of stock options $ (95,000)   $ 1,000   (96,000)      
Issuance of restricted common stock, shares     9,000          
Cancellation and retirement of restricted common stock, shares     (10,000)          
Cancellation and surrender of restricted common stock (347,000)       (347,000)      
Stock-based compensation expense 2,200,000       2,200,000      
Dividends on common stock (3,607,000)       (3,607,000)      
Convertible notes conversions $ (1,424,000)       (1,424,000)      
Treasury stock acquired, shares (324,700)   (325,000)          
Treasury stock acquired $ (12,301,000)             (12,301,000)
Ending balance, shares outstanding at Jun. 30, 2021     17,826,000          
Ending Balance at Jun. 30, 2021 232,871,000   $ 262,000   237,891,000   109,069,000 (114,351,000)
Beginning balance, shares outstanding at Mar. 31, 2021     18,048,000          
Beginning Balance at Mar. 31, 2021 251,503,000   $ 261,000   238,056,000   115,236,000 (102,050,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) (6,167,000)           (6,167,000)  
Isuuance of common stock, shares     14,000 5,000        
Issuance of common stock $ 361,000 160,000     361,000 160,000    
Exercise of stock options, shares 180,629   85,000          
Exercise of stock options $ 53,000   $ 1,000   52,000      
Cancellation and retirement of restricted common stock, shares     (1,000)          
Cancellation and surrender of restricted common stock 0       0      
Stock-based compensation expense 1,070,000       1,070,000      
Dividends on common stock $ (1,808,000)       (1,808,000)      
Treasury stock acquired, shares (324,700)   (325,000)          
Treasury stock acquired $ (12,301,000)             (12,301,000)
Ending balance, shares outstanding at Jun. 30, 2021     17,826,000          
Ending Balance at Jun. 30, 2021 232,871,000   $ 262,000   237,891,000   109,069,000 (114,351,000)
Beginning balance, shares outstanding at Dec. 31, 2021     15,332,000          
Beginning Balance at Dec. 31, 2021 128,015,000   $ 263,000   236,809,000   135,462,000 (244,519,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) 27,301,000           27,301,000  
Isuuance of common stock, shares     25,000 5,000        
Issuance of common stock $ 1,001,000 246,000     1,001,000 246,000    
Exercise of stock options, shares 18,736   9,000          
Exercise of stock options $ (22,000)       (22,000)      
Cancellation and retirement of restricted common stock, shares     (5,000)          
Cancellation and surrender of restricted common stock (205,000)       (205,000)      
Stock-based compensation expense 2,839,000       2,839,000      
Dividends on common stock $ (3,455,000)       (3,455,000)      
Treasury stock acquired, shares (695,496)   (695,000)          
Treasury stock acquired $ (34,234,000)             (34,234,000)
Other, shares     27,000          
Other (1,358,000)       (1,358,000)      
Ending balance, shares outstanding at Jun. 30, 2022     14,698,000          
Ending Balance at Jun. 30, 2022 122,844,000   $ 263,000   238,571,000   162,763,000 (278,753,000)
Beginning balance, shares outstanding at Mar. 31, 2022     14,889,000          
Beginning Balance at Mar. 31, 2022 120,021,000   $ 263,000   238,423,000   151,864,000 (270,529,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) 10,899,000           10,899,000  
Isuuance of common stock, shares     12,000 2,000        
Issuance of common stock $ 398,000 $ 99,000     398,000 $ 99,000    
Exercise of stock options, shares 0              
Cancellation and retirement of restricted common stock, shares     0          
Cancellation and surrender of restricted common stock $ 2,000       2,000      
Stock-based compensation expense 1,379,000       1,379,000      
Dividends on common stock $ (1,730,000)       (1,730,000)      
Treasury stock acquired, shares (205,496)   (205,000)          
Treasury stock acquired $ (8,224,000)             (8,224,000)
Ending balance, shares outstanding at Jun. 30, 2022     14,698,000          
Ending Balance at Jun. 30, 2022 $ 122,844,000   $ 263,000   $ 238,571,000   $ 162,763,000 $ (278,753,000)